HELIX is a Biotech company based in San Francisco, California. It has raised $225M in total funding. Latest round: Series D.
HELIX funding overview
HELIX is a Biotech company based in San Francisco, California. HELIX has raised $225M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series D announced in July 2021. The round record for HELIX runs through 2021; nothing later has been disclosed. Investors on record include Kleiner Perkins, 01 Advisors, Coatue, Upfront Ventures, Founders Fund, Ludlow Ventures and 1 others. 7 distinct backers are named across the disclosed rounds.
HELIX has raised $225M in total disclosed funding across the rounds on record.
Who has invested in HELIX?
Kleiner Perkins, 01 Advisors, Coatue, Upfront Ventures, Founders Fund, Ludlow Ventures are named among the investors backing HELIX.
What was the latest HELIX funding round?
The most recent disclosed round is a Series D, announced in July 2021.
Where is HELIX based?
HELIX is based in San Francisco, California.
What sector does HELIX operate in?
HELIX is tracked under Biotech from San Francisco, California, with $225M in disclosed funding.
When did HELIX last raise?
The last disclosed HELIX round closed in July 2021 at Series D.
We update the HELIX record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in San Francisco and their backers are listed below.
